1-7 of 7
Authors: Mamoru Kato
Sort by
Journal Article
GCT-09. Transcriptome and methylome profiles of CNS germ cell tumors and their comparison with testicular counterpart Open Access
Hirokazu Takami and others
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i56, https://doi.org/10.1093/neuonc/noac079.203
Published: 03 June 2022
Journal Article
Transcriptome and methylome analysis of CNS germ cell tumor finds its cell-of-origin in embryogenesis and reveals shared similarities with testicular counterparts Free
Hirokazu Takami and others
Neuro-Oncology, Volume 24, Issue 8, August 2022, Pages 1246–1258, https://doi.org/10.1093/neuonc/noac021
Published: 08 February 2022
Journal Article
GCT-52. TRANSCRIPTOME OF CENTRAL NERVOUS SYSTEM GERM CELL TUMOR REVEALS ITS PATHOGENESIS AND CONTRASTS WITH TESTICULAR COUNTERPARTS IN INTEGRATED OMICS ANALYSIS Open Access
Hirokazu Takami and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Pages iii338–iii339, https://doi.org/10.1093/neuonc/noaa222.270
Published: 04 December 2020
Journal Article
GCT-34. ELUCIDATION OF THE MECHANISMS OF TUMORIGENESIS IN INTRACRANIAL GERM CELL TUMOR BY WHOLE GENOME SEQUENCE Open Access
Yuki Yamagishi and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Pages iii334–iii335, https://doi.org/10.1093/neuonc/noaa222.253
Published: 04 December 2020
Journal Article
GCT-62. DISSECTING INTRATUMORAL HETEROGENEITY OF CENTRAL NERVOUS SYSTEM GERM CELL TUMORS BY SINGLE-CELL RNA-SEQUENCING Open Access
Tomoyuki Nakano and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Pages iii340–iii341, https://doi.org/10.1093/neuonc/noaa222.279
Published: 04 December 2020
Journal Article
QOLP-07. HEALTH-RELATED QUALITY OF LIFE AND SYMPTOM BURDEN IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA TREATED WITH BEVACIZUMAB BEYOND PROGRESSION: A PROSPECTIVE TRIAL Free
Shota Tanaka and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii176, https://doi.org/10.1093/neuonc/noaa215.732
Published: 09 November 2020
Journal Article
ACTR-04. BIOMARK: A PHASE II STUDY OF BEVACIZUMAB BEYOND PROGRESSION FOR NEWLY DIAGNOSED GLIOBLASTOMA: SAFETY, EFFICACY AND PROSPECTIVE BIOMARKER ANALYSIS Free
Koichi Ichimura and others
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi12–vi13, https://doi.org/10.1093/neuonc/noz175.048
Published: 11 November 2019
Advertisement
Advertisement